Key result
Lowest HDL-C quintile linked to ~59% higher 1-year recurrent stroke risk versus highest quintile.
Why the study?
Data on the association between HDL-C levels and adverse outcomes in patients with diabetes mellitus remain limited and controversial.
Does low HDL-C increase the risk of recurrent stroke and MACE in acute ischemic stroke patients with diabetes mellitus?
Population
3824 acute ischemic stroke patients with diabetes mellitus from the Third China National Stroke Registry
Comparison
Quintiles of HDL-C levels
Design
Registry-based cohort study
Follow-up
1 year
Authors
Loading...
Low HDL-C levels are associated with a significantly higher risk of recurrent stroke and MACE within 1 year in acute ischemic stroke patients with diabetes mellitus.
Cohort (n=3,824)
Yes
Does low HDL-C increase the risk of recurrent stroke and MACE in acute ischemic stroke patients with diabetes mellitus?
Hazard Ratio: 1.59 (95% CI 1.12–2.25)
Low HDL-C levels are associated with a significantly higher risk of recurrent stroke and MACE within 1 year in acute ischemic stroke patients with diabetes mellitus.
Hu et al. (2021) conducted a cohort in Acute ischemic stroke with diabetes mellitus (n=3,824). Lowest quintile of HDL-C vs. Highest quintile of HDL-C was evaluated on Recurrent stroke within 1 year (HR 1.59, 95% CI 1.12-2.25). The lowest quintile of HDL-C was associated with a higher risk of recurrent stroke (HR 1.59; 95% CI 1.12-2.25) and MACEs (HR 1.53; 95% CI 1.09-2.15) at 1 year compared to the highest quintile.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: